학술논문

Switch from sequestering to anti-CD20 depleting treatment: disease activity outcomes during wash-out and in the first 6 months of ocrelizumab therapy
Document Type
Article
Source
In: Multiple Sclerosis Journal. (Multiple Sclerosis Journal, January 2022, 28(1):93-101)
Subject
Language
English
ISSN
14770970
13524585